F R Appelbaum|H M Shulman - JoVE Visualize

Showing results (231-240 of 464) with videos related to

Pageof 47

Sort By:

Bone Marrow Transplantation|November 1, 1994

Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.

Blood|June 1, 1994

Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow graftsR Storb, R F Raff, F R Appelbaum, et al.

Bone Marrow Transplantation|May 1, 1991

Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3C Anasetti, P J Martin, R Storb, et al.

Cancer Research|March 1, 1992

Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibodyD C Matthews, C C Badger, D R Fisher, et al.

Experimental Hematology|September 1, 1989

Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factorF G Schuening, R Storb, S Goehle, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.

Blood|December 1, 1993

Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantationJ Nemunaitis, F R Appelbaum, J W Singer, et al.

Bone Marrow Transplantation|December 2, 2000

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.

Blood|August 1, 1994

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.

Pharmacoeconomics|June 7, 1994

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.

Pageof 47

Showing results (231-240 of 464) with videos related to

Sort By:

Pageof 47

Bone Marrow Transplantation|November 1, 1994

Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.

Blood|June 1, 1994

Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow graftsR Storb, R F Raff, F R Appelbaum, et al.

Bone Marrow Transplantation|May 1, 1991

Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3C Anasetti, P J Martin, R Storb, et al.

Cancer Research|March 1, 1992

Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibodyD C Matthews, C C Badger, D R Fisher, et al.

Experimental Hematology|September 1, 1989

Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factorF G Schuening, R Storb, S Goehle, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.

Blood|December 1, 1993

Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantationJ Nemunaitis, F R Appelbaum, J W Singer, et al.

Bone Marrow Transplantation|December 2, 2000

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.

Blood|August 1, 1994

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.

Pharmacoeconomics|June 7, 1994

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.

Pageof 47